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Abstract
Human DJ-1 is a cytoprotective protein whose absence causes Parkinson's disease
and is also associated with other diseases. DJ-1 has an established role as a redox-
regulated protein that defends against oxidative stress and mitochondrial dysfunction. Multiple studies have suggested that DJ-1 is also a protein/nucleic acid deglycase
that plays a key role in the repair of glycation damage caused by methylglyoxal (MG),
a reactive α-keto aldehyde formed by central metabolism. Contradictory reports suggest that DJ-1 is a glyoxalase but not a deglycase and does not play a major role in
glycation defense. Resolving this issue is important for understanding how DJ-1 protects cells against insults that can cause disease. We find that DJ-1 reduces levels of
reversible adducts of MG with guanine and cysteine in vitro. The steady-state kinetics
of DJ-1 acting on reversible hemithioacetal substrates are fitted adequately with a
computational kinetic model that requires only a DJ-1 glyoxalase activity, supporting the conclusion that deglycation is an apparent rather than a true activity of DJ-1.
Sensitive and quantitative isotope-dilution mass spectrometry shows that DJ-1 modestly reduces the levels of some irreversible guanine and lysine glycation products
in primary and cultured neuronal cell lines and whole mouse brain, consistent with a
small but measurable effect on total neuronal glycation burden. However, DJ-1 does
not improve cultured cell viability in exogenous MG. In total, our results suggest that
DJ-1 is not a deglycase and has only a minor role in protecting neurons against methylglyoxal toxicity.
KEYWORDS

deglycase, enzyme mechanism, glycation stress, glyoxalase, PARK7, Parkinson's disease

Abbreviations: AMU, atomic mass unit; BDNF, brain-derived neurotrophic factor; CEdG, N2 -(1-c arboxyethyl)-2′-deoxyguanosine; CEG, N2 -(1-c arboxyethyl)-2′-guanosine; CEL,
N ε -(1-c arboxyethyl)-L-lysine; cMG-d G, 1,N2 -(1,2-dihydroxy-2-methyl)ethano-2′-deoxyguanosine; CoA, coenzyme A; dG, deoxyguanosine; DNPH, 2,4-dinitrophenylhydrazine; DTT,
dithiothreitol; GDNF, glial cell line-derived neurotrophic factor; GSH, glutathione; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; HRP, horseradish peroxidase; iPSC,
induced pluripotent stem cell; LC–MS, liquid chromatography-mass spectrometry; MG, methylglyoxal; MG-CEdG, N2 -(1-c arboxyethyl)-7-1-hydroxy-2-oxopropyl-deoxyguanosine; NAC,
N-acetyl-l-c ysteine; PBS, phosphate-buffered cysteine; shRNA, short hairpin RNA.
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I NTRO D U C TI O N

assay conditions between studies (Andres-Mateos et al., 2007; Chen
et al., 2010; Mitsugi et al., 2013; Olzmann et al., 2004).

DJ-1 is a 20 kDa homodimeric protein that is conserved from

Considerable interest has been generated by reports that human

bacteria to humans (Bandyopadhyay & Cookson, 2004; Lucas &

DJ-1 is a glutathione-independent glyoxalase that converts glyoxal

Marin, 2007; Wilson et al., 2005). In humans, mutations in DJ-1

to glycolate and methylglyoxal (MG) to L-lactate (Hasim et al., 2014;

(PARK7) cause rare forms of autosomal recessive parkinsonism

Kwon et al., 2013; Lee et al., 2012; Zhao et al., 2014). In addition,

(Bonifati et al., 2003). Eukaryotic DJ-1 promotes cell survival, par-

DJ-1 has been reported to be a deglycase that repairs early glyca-

ticularly during oxidative stress or mitochondrial dysfunction, and

tion adducts that MG forms with DNA, RNA, small molecule thiols,

is found in multiple cellular compartments (Cali et al., 2015; Canet-

and proteins (Matsuda et al., 2017; Richarme et al., 2015; Richarme

Aviles et al., 2004; Junn et al., 2009; Shadrach et al., 2013; Taira

et al., 2017; Richarme et al., 2018; Richarme & Dairou, 2017; Sharma

et al., 2004). Consistent with its cytoprotective role, DJ-1 is highly

et al., 2019; Zheng et al., 2019). Both of these activities could protect

expressed in several types of cancers (Cao et al., 2017; Hod, 2004;

cells by detoxifying reactive α-ketoaldehydes produced by metabo-

Le Naour et al., 2001; MacKeigan et al., 2003; Nagakubo et al., 1997)

lism, but in distinct ways. A glyoxalase removes MG directly, while a

and it plays important roles in maintaining normal function in lung

deglycase acts on glycated substrates and repairs primary damage,

(Bahmed et al., 2016; Bahmed et al., 2019), eye (Martin-Nieto

indirectly removing MG by repairing its initial adducts. The glyox-

et al., 2019; Shadrach et al., 2013), and kidney (Cuevas et al., 2012;

alase activity of DJ-1 has been widely reproduced but its reported

Eltoweissy et al., 2011). A conserved cysteine (Cys106) in DJ-1 is

kcat is ~10 4–105 lower than the primary glutathione-dependent

both essential for its cytoprotective activity during oxidative stress

glyoxalase Glo1 (Marmstal et al., 1979; Thornalley, 1990). By con-

(Bahmed et al., 2019; Canet-Aviles et al., 2004; Shadrach et al., 2013;

trast, DJ-1's deglycase activity has been controversial, and a re-

Taira et al., 2004; Waak et al., 2009; Xu et al., 2018) and is oxidation-

cent study suggests that deglycation may be a secondary effect of

prone, forming cysteine sulfinate (-SO2−) and sulfonate (-SO3−) spe-

DJ-1 acting on MG that is in rapid equilibrium with reversible MG

cies (Canet-Aviles et al., 2004; Kinumi et al., 2004; Mita et al., 2018).

adducts (Andreeva et al., 2019). Some reports indicate that DJ-1-

The formation of Cys106-SO2− has been proposed as one of several

mediated deglycation is important for repairing certain proteins

mechanisms that allow DJ-1 to act as a sensor of cellular redox state

(Galligan et al., 2018; Richarme et al., 2015; Richarme et al., 2017;

and to activate cytoprotective responses through the PTEN/Akt

Sharma et al., 2019; Zheng et al., 2019), while others have indicated

(Oswald et al., 2018) and ASK1 (Cao et al., 2014; Waak et al., 2009)

that DJ-1 has a negligible effect on total cellular glycation burden

signaling pathways as well as by altering pathological protein aggre-

(Andreeva et al., 2019; Pfaff et al., 2017) and does not deglycate

gates (Atieh et al., 2021; Kumar et al., 2019; Zhou et al., 2006). Other

disease-relevant proteins such as α-synuclein (Atieh et al., 2021). In

activities proposed for DJ-1 include protease (Mitsugi et al., 2013;

addition, several reports indicate that DJ-1 has no effect on cell via-

Olzmann et al., 2004), esterase (Vazquez-Mayorga et al., 2016),

bility under glycation stress in systems ranging from cultured human

chaperone (Lee et al., 2003; Shendelman et al., 2004), transnitrosy-

cells to yeast (Andreeva et al., 2019; Natkanska et al., 2017; Pfaff

lase (Choi, Nakamura, et al., 2014), and an RNA binding protein

et al., 2017; Zhao et al., 2014). Therefore, both the true substrate and

(Hod et al., 1999; van der Brug et al., 2008). Very recently, DJ-1 was

physiological relevance of DJ-1's anti-glycation action are debated

shown to prevent protein damage by derivatives of 1,3, bisphospho-

(Jun & Kool, 2020).

glycerate (Heremans et al., 2022). Despite years of intensive study

Given the importance of DJ-1 in the etiology of several diseases,

motivated by its biomedical importance, the molecular activities of

it is important to determine if a glyoxalase/deglycase activity is a

DJ-1 that are responsible for its role in cell survival remain incom-

major contributor to DJ-1 cytoprotection. If true, such an activity

pletely understood.

would have wide-reaching ramifications for the molecular etiology

It has long been suspected that DJ-1 may possess an enzy-

of several diseases. For example, a primary glyoxalase/deglycase ac-

matic activity. Cys106 has a low pKa value of 5.4 and makes a hy-

tivity for DJ-1 implies that reactive dicarbonyl species play a key role

drogen bond with a conserved protonated glutamic acid residue

in the etiology of parkinsonism, as somatic DJ-1 deficiency invari-

(Glu18) (Witt et al., 2008), which are features suggestive of an en-

ably results in Parkinson's disease in humans (Bonifati et al., 2003). A

zyme active site. These residues are conserved in the large DJ-1/

dominant glyoxalase/deglycase model for DJ-1 cytoprotection also

PfpI superfamily (Wei et al., 2007), which contains well-established

implies that cells possessing enhanced ability to detoxify dicarbonyls

enzymes such as archaeal PfpI proteases (Du et al., 2000; Halio

are prone to neoplastic transformation, as DJ-1 is an oncogene and

et al., 1996), isocyanide hydratases (Goda et al., 2001; Goda

its levels are elevated in multiple cancers (Cao et al., 2017). Because

et al., 2002; Lakshminarasimhan et al., 2010), and the Hsp31 fam-

even low levels of glycation can cause cellular dysfunction (Moraru

ily of glutathione-independent glyoxalases (Subedi et al., 2011). In

et al., 2018), quantitative methods for measuring macromolecular

all of these enzymes, the conserved cysteine residue is a catalytic

glycation such as isotope dilution mass spectrometry are needed to

nucleophile and the protonated glutamic/aspartic acid is a probable

accurately evaluate the potential influence of DJ-1 on cellular glyca-

general acid/general base. In contrast to these validated enzymes,

tion burden.

most proposed enzymatic functions of human DJ-1 have been con-

In this work, we use in vitro assays to show that DJ-1 cannot

troversial and confounded by weak apparent activities and variable

deglycate irreversible adducts of MG and guanine but can deglycate

|
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reversible adducts by an indirect mechanism. Steady-state enzyme

University of Nebraska-Lincoln) confirmed that DJ-1 was purified in

kinetics using purified MG and reversible hemithioacetal substrates

the fully reduced form and that H2O2 oxidation increased the intact

support a prior proposal that DJ-1's apparent deglycase activity is

mass of DJ-1 by 32 a.m.u, consistent with Cys106-SO2− formation.

because of its glyoxalase activity acting on free MG. Our kinetic con-

In addition, preparations of DJ-1 were tested for proper folding by

stants are in reasonable agreement with those recently reported by

crystallization and X-ray crystal structure analysis. All preparations

Andreeva et al. (Andreeva et al., 2019) and confirm that DJ-1's in

of the protein crystallize readily and produce crystal structures that

vitro glyoxalase activity is many orders of magnitude lower than that

are essentially identical (C α RMSD ~0.05 Å) to prior human DJ-1

of glyoxalase I (Glo1). Kinetic modeling demonstrates that the glyoxalase activity of DJ-1 is sufficient to explain the apparent deglycation

structures deposited in the Protein Data Bank (e.g., accession code
1P5F, 5SY6).

kinetics. We use quantitative isotope-dilution mass spectrometry to
show that DJ-1 measurably reduces the total DNA, RNA, and protein glycation burden in various neuronal cell lines and mouse brain,

2.2 | In vitro deglycase and glyoxalase assays

although the effect size is small. Cell survival in MG stress is unaffected by DJ-1 status, suggesting that DJ-1 plays a minor role in

Commercial methylglyoxal (MG) is known to be contaminated with

glycation defense.

several species that may interfere with kinetic measurements.
Therefore, MG was purified from pyruvaldehyde-1-dimethyl ac-

2

|

M ATE R I A L A N D M E TH O DS

2.1 | Protein expression and purification

etal as previously reported (Shuck et al., 2018) and stored frozen
in small aliquots at −80°C until needed. 10 mM N-acetyl-L-cysteine
(NAC; Alfa Aesar catalog number A15409), glutathione (GSH;
Acros Organics catalog number 120000250), or coenzyme A (CoA;
Affymetrix catalog number 13787) were mixed with 10 mM of

The gene for human DJ-1 was cloned between the NdeI and XhoI

freshly thawed methyglyoxal and incubated at 25°C until the ab-

sites of Escherichia coli expression vector pET15b and the C106S,

sorption at 288 nm was stable (~1 h), indicating that hemithioacetal

E18D, and E18N mutants were generated by site-directed mutagen-

formation was at equilibrium.

esis and previously described (Witt et al., 2008). The constructs

DJ-1 was dialyzed against degased PBS buffer (137 mM NaCl,

were transformed into E. coli BL21 (DE3) cells and protein expres-

2.7 mM KCl, 10 mM Na2HPO 4, 1.8 mM KH2PO 4 pH 7.4) immediately

sion and purification were performed as described previously (Lin

before the kinetic measurements. This buffer was chosen because

et al., 2012). Briefly, the protein was purified by Ni2+ metal affinity

it was used by both Richarme et al. (Richarme et al., 2015) and Pfaff

chromatography, the hexahistitdine tag was removed from recombi-

et al. (Pfaff et al., 2017), thereby facilitating direct comparison of our

nant DJ-1 by thrombin cleavage, and the protein was passed through

results to prior reports. We note that DJ-1 is reported to be less ac-

Hi-Q anion exchange column (Bio-Rad Laboratories) to remove

tive in PBS than in other buffers (Mulikova et al., 2021), which might

minor nucleic acid contamination. Thrombin was removed using

be relevant for reconciling the low glyoxalase activity of DJ-1 in vitro

benazamidine-sepharose 4 resin (Cytiva catalog number 17512310).

with its observed effects in vivo. Andreeva et al. recently reported

All proteins ran as a single band on overloaded Coomassie-stained

new equilibrium constants for the formation of MG-hemithioacetals,

SDS-PAGE and were concentrated using a 10-kDa cutoff centrifu-

which are substantially lower than prior values (Andreeva

gal concentrator (Millipore) to 20 mg/ml in storage buffer (25 mM

et al., 2019). Therefore, not all of the added MG and thiol react to

HEPES pH 7.5, 100 mM KCl, 2–5 mM DTT). DJ-1 concentration was

form the hemithioacetal species (Mulikova et al., 2021). Initial con-

determined by the absorbance at 280 nm using a calculated extinc-

centrations of the NAC-MG and GSH-MG hemithioacetal substrates

tion coefficient at 280 nm of 4400 M−1 cm−1. The purified protein

were determined using the updated molar extinction coefficient

in storage buffer was snap-frozen in liquid nitrogen and stored at

of 300 and 250 M−1 cm−1, respectively (Andreeva et al., 2019). The

−80°C.

CoA-MG hemithioacetal molar extinction coefficient has not been

DJ-1 was oxidized at Cys106 as described previously (Lin

reported, so it was presumed to be the same as NAC-MG. Initial con-

et al., 2012). Briefly, 0.25 mM DJ-1 in storage buffer was dialyzed

centrations of the hemithioacetal substrates were determined using

against PBS (pH 7.4), followed by the addition of H2O2 (Invitrogen)

A 288. The reaction was initiated by the addition of DJ-1 (wild-t ype,

to a final concentration of 1.75 mM (i.e., a 7:1 molar ratio of H2O2

Cys106-SO2−, C106S, E18N, and E18D) to 10 μM final concentration.

to DJ-1 monomer) and the mixture was incubated on ice for 45 min.

The A 288 was measured for 6 min at 25°C using a Cary50 UV–visible

Unreacted H2O2 was removed by Bio-Gel P-6 desalting resin. Prior

spectrophotometer (Varian) and always showed a linear decrease

work has shown that this procedure selectively oxidizes Cys106 in

over this timeframe. The slope of the best-fit line to the measured

human DJ-1 (Blackinton et al., 2009; Lin et al., 2012; Zhou et al., 2006).

decrease in A 288 signal was used to calculate the initial rate (V0) of

Electrospray mass spectrometry using an Agilent 1200 LC system

hemithioacetal consumption. Because the hemithioacetal sponta-

(Agilent Technologies) with the electrospray ionization (ESI) source

neously degrades in aqueous solutions, a buffer-alone baseline was

of a Bruker Solarix—70 hybrid Fourier transform mass spectrometer

measured in order to correct for non-catalytic loss of 288 nm signal.

(Redox Biology Center [RBC] Mass Spectrometry Core Facility, the

The difference between the buffer-alone and buffer-enzyme curve
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S C H E M E 1 Coupled equilibria for
DJ-1 action on methylglyoxal and the
methylglyoxal adduct with N-acetyl
cysteine (NAC).

was taken to reflect DJ-1 activity. All measurements were repeated

equilibrium constant for Scheme 1 was fixed using a previously de-

at least three times and average values with associated standard de-

termined value of 500 M−1 (Andreeva et al., 2019). The rate constants

viations are reported.

in Scheme 1 were adjusted to globally fit all progress curve data,

DJ-1 glyoxalase activity was measured using a coupled assay of

where best-fit rate constants can be found in Table 2. Confidence

L-lactate oxidase and Amplex Red/horseradish peroxidase (HRP). In

intervals for parameters were obtained by the KinTek software

this assay, DJ-1 glyoxalase activity generates L-lactate (Choi, Kim,

(Johnson et al., 2009a) by finding rates constants that produce a

et al., 2014), which is oxidized by L-lactate oxidase and molecular

0.83 relative error or chi-squared ratio ( 𝜒 )to the best-fit found in

oxygen to generate pyruvate and H2O2. The liberated H2O2 and

Table 2. DJ-1-catalyzed L-lactate formation was monitored through

Amplex Red are co-substrates for HRP, generating fluorescent re-

a coupled lactate oxidase and Amplex red assay as described above.

sorufin. The rate of H2O2 generation was monitored using the

Lactate oxidation and subsequent formation of H2O2 to produce

Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit (Invitrogen).

fluorescence were made non-rate limiting in the simulation by in-

Various concentrations of purified MG were added to air-saturated

creasing the rate constant for formation of fluorescent product to

Amplex Red working solution (including the Amplex Red reagent

an arbitrary value of 3.9 × 10 4 min−1. Simulation of the fluorescent

and HRP) and 0.4 units of L-lactate oxidase (Sigma, catalog number

product using a linear fluorescence coefficient was based on a H2O2

𝜒 2best
2
i

L9795) in reaction buffer (50 mM sodium phosphate, pH 7.4, as pro-

Amplex Red standard curve but then optimized to 3.63 × 107 M−1 in

vided in the kit) at 25°C. The reaction was initiated by adding human

the fitting.

DJ-1 to a final concentration 0.1 μM. H2O2 generation was measured for five min using a Cary Eclipse spectrofluorimeter (Varian)
with an excitation wavelength at 540 nm and emission wavelength

2.4 | Culture of M17 neuroblastoma cell lines

of 590 nm. The measured rates are linear in DJ-1 concentration and
do not change significantly when the concentration of the coupling

Clonal M17 cell lines stably expressing different control and DJ-1

enzymes is increased, confirming that the coupling enzymes were

shRNA sequences were prepared as described previously (van der

not rate-limiting. All reaction rates were linear over this timeframe

Brug et al., 2008). The efficiency of shRNA knockdown was deter-

and the slope of the best-fit line was converted to H2O2 concentra-

mined using western blotting (Figure S1). Proteins from stable M17

tion using a standard curve generated with known concentrations

cell lines were extracted with lysis buffer (1x cell lysis buffer (Cell

of H2O2. All rates were measured a minimum of three times per sub-

Signaling Technology, catalog number 9803) and then separated

strate concentration.

on 4–20% Criterion TGX gels (Bio-R ad) and transferred to PVDF
membranes using a Trans-Blot Turbo system (Bio-R ad). Antibodies

2.3 | DJ-1 glyoxalase/deglycase kinetic
simulations and data fitting

to DJ-1 (Abcam catalog number ab76008, 1:4000 dilution) and β-
actin (Sigma catalog number A1978, 1:40 000 dilution) were applied overnight at 4°C, followed by secondary antibodies for 1 h at
room temperature (22°C). Blots were imaged on a Li-Cor Odyssey

Data were fit using KinTek global kinetic explorer software (version

CL-x imager. This line is not known to be a commonly misidenti-

10.1.8.beta). The KinTek software simulates reactions by automati-

fied line and cells were used within 10 passages of stable shRNA

cally deriving the corresponding system of rate equations, solving

modification. Cells were cultured to confluency in Opti-MEM

them using numerical integration, and fitting kinetic data using

(ThermoFisher, catalog number 31985088) + 10% fetal bovine

nonlinear least squares (Johnson et al., 2009b). Initial conditions

serum (Gemini Bio-Products, catalog number 900–108) + 5 μg/ml

were set using the experimental values. Loss of MG-NAC hemith-

Blasticidin (ThermoFisher, catalog number A1113903). For treat-

ioacetal was simulated using a molar extinction value at 288 nm of

ment experiments, control and DJ-1 shRNA M17 cells (n = 4) were

300 M−1 cm−1, along with the mechanism (Scheme 1) and rate con-

treated with either regular media or buthionine sulfoximine (43 mM)

stants described in Table 2 using experimental conditions described

for 8 h. Following treatment, cells were processed for DNA, RNA,

above. The simulation recapitulated the experimental protocol,

and protein isolation (see below). Treatment concentrations used

simulating initial hemoithioacetal formation by mixing 10 mM of MG

were the IC50 determined by toxicity following 24 h treatment ex-

and 10 mM NAC for 2 h, diluted as indicated in Figure 4, and mixed

posure using 0, 0.1, 1, 10, and 100 mM for buthionine sulfoximine

with DJ-1 (10 μM) for 2 min prior to data collection at 288 nm. The

(Zepeta-Flores et al., 2018).

|
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2.5 | Murine primary neuronal cultures

2.8 | RNA extraction for glycation analysis

Cortical neuron-enriched primary cultures were prepared from wild-

All cell lines were seeded at ~1 × 106 per 12 well with n = 4 wells

type and DJ-1 knockout mouse pups (n = 18–24) between postna-

used for RNA, DNA, or protein extraction. Cells were lysed using

tal days 1–2 and cultured in Basal medium eagle (+ 1x B-27 minus

0.4 ml TRIzol™ reagent (ThermoFisher, catalog number 15596026)

vitamin A, 1x N2 supplement, 0.5 mM glutamine, 45% glucose, 1x

and 0.08 ml chloroform. Following centrifugation for 15 min at 4°C at

Penicillin–Streptomycin). Pups were sacrificed using rapid decapi-

12 000 g, the top aqueous layer was transferred to a new Eppendorf

tation. Pups were not sexed at the time of sacrifice. Cultures were

tube. RNA was precipitated with the addition of 0.2 ml isopropanol

made by pooling samples from six brains and then plating cells.

followed by centrifugation for 10 min. RNA pellet was washed with
0.4 ml 75% ethanol and centrifuged for 5 min at 7500 g. Supernatant

2.6 | Monolayer forebrain neuronal differentiation
from human iPSC

was discarded and pellet was air-dried then resuspended in 20 μl
RNase-free water. To complete solubilizing the RNA, incubation in
water bath at 55°C occurred for 15 min. RNA from brain samples was
processed using the same protocol. RNA concentration was quanti-

A commercial iPSC line (ThermoFisher, catalog number A18945) and

fied using spectrophotometer.

the DJ-1 knockout iPSC line HT-188 (Mazza et al., 2021) were grown
on a layer of MEFs (MTI-GlobalStem, catalog number GSC-6201G)
in Essential 8TM media (ThermoFisher, catalog number A1517001)

2.9 | DNA extraction for glycation analysis

until 100% confluent. Confluent cells were transitioned to N3 media
(50% DMEM/F12, 50% Neurobasal with 1x Penicillin–Streptomycin,

Cells were rinsed, scraped, and pelleted using sterile PBS. Cells were

0.5x B-27 minus vitamin A, 0.5x N2 supplement, 1x Glutamax, 1x

resuspended in equal volumes PBS and phenol:chloroform:isoamyl

NEAA, 0.055 mM 2-mercaptoethanol and 1 μg/ml insulin) plus 1.5 μM

(25:24:1) and spun for 5 min at 16000xg. The top aqueous layer was

Dorsomorphin (Tocris Bioscience) and 10 μM SB431542 (Stemgent)

transferred to a new Eppendorf tube. DNA was precipitated by add-

daily for 11 days. On days 12–15, cells were fed each day with N3

ing 0.5× volume of 7.5 M ammonium acetate and 3x volume of 100%

without Dorsomorphin and SB431542. On days 16–20, N3 was sup-

ethanol then stored at −20°C overnight. DNA was pelleted by cen-

plemented with 0.05 μM retinoic acid. On day 20, cells were split 1:2

trifugation for 30 min at 4°C at 16 000 g. Supernatant was removed

with trypsin and seeded with ROCK inhibitor onto poly-l-ornithine

and pellet was washed with 70% ethanol. Following centrifugation,

(Sigma), fibronectin, and laminin-coated plates. From days 21 to time

supernatant was removed, pellet was air-dried and resuspended in

of extraction, cells were fed with N4 media (same as N3 plus 0.05 μM

100 μl autoclaved water. DNA from brain samples was isolated using

retinoic acid, 2 ng/ml BDNF and 2 ng/ml GDNF). The maximum pas-

the DNeasy Blood and Tissue kit (Qiagen, catalog number 69504).

sage used for both iPSC lines was p11. Neither of the iPSC lines used

DNA concentration was quantified using spectrophotometer.

is listed as commonly misidentified cell lines by the International Cell
Line Authentication Committee. The characterization, karyotyping, sequencing, and confirmation of DJ-1 ablation for the iPSC lines used in

2.10 | Protein extraction for glycation analysis

the current study is described in (Mazza et al., 2021).
Cells were scraped and lysed with lysis buffer (1x cell lysis buffer

2.7 | DJ-1 knockout mice

(Cell Signaling Technology, catalog number 9803), 1x protease inhibitor (Sigma, catalog number 4693159001), and 1x phosphatase
inhibitor (ThermoFisher, catalog number 78427)). Lysed cells were

All animal work performed in this study was performed after ap-

set to rotate for 30 min at 4°C then spun at >20 000 g for 8 min at

proval of the National Institute on Aging (NIA) Animal Care and Use

4°C. Supernatant was transferred to a new Eppendorf tube and

Committee, Animal Study Protocol number 463-LNG-2024 in compli-

protein concentration was measured using the Pierce™ 660 nm pro-

ance with the ARRIVE guidelines. This study was not pre-registered.

tein assay. Protein from brain samples was extracted using a similar

Mice were not treated so no randomization was performed to al-

protocol.

locate subjects. Male and female C57Bl6/J (wild-t ype [WT], n = 5
animals) and DJ-1 knockout (RRID:MMRRC_032090-MU from Dr.
Huaibin Cai, n = 6 animals) mice were given access to food and water
ad libitum and housed in a facility with 12-h light/dark cycles. Mice

2.11 | HPLC analysis of MG reaction with dG in the
presence of DJ-1

were sacrificed by CO2 inhalation between 20 and 22 months of age
by and brains were flash-frozen and stored at −80°C. Brains were

MG was synthesized as previously described (Jaramillo et al., 2017)

homogenized into a frozen powder using liquid nitrogen and sepa-

and reacted (5 mM) with dG (0.5 mM) in 50 mM sodium phos-

rated for DNA, RNA, and protein extractions. No exclusion criteria

phate, pH 7.5 for 1 h at 37°C. DJ-1 (5 μM) was added for an ad-

were pre-determined, and all mice were included in the analysis.

ditional 24 h. Reactions were also performed in which DJ-1 was
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added concomitantly with MG and dG. Following incubation,

2.14 | Statistical analysis

reactions were analyzed on an Agilent 1100 HPLC as previously
described (Shuck et al., 2018). Reactions with dinitrophenylhydra-

No power calculations were used to predetermine sample sizes, al-

zine (DNPH) were performed by making a 10 mM DNPH stock in

though post hoc power calculations for the relevant figures were

2.5 M HCl with dilution to 5 mM in H2O. DNPH (5 mM) was added

performed as described in the Supplemental Material, Tables S1

to reactions for 15 min followed by the addition of 2.5 M NaOH

and S2. Normality was tested using the Shapiro–Wilk test for small

prior to injection on HPLC. Absorbance from 210 to 510 nm was

datasets and the D'Agostino and Pearson test with higher n datasets

monitored.

(e.g., n = 8). Datasets passed normality when these tests are applied
in this way, although the larger n = 8 datasets did not pass normality

2.12 | Mass spectrometric analysis of CEdG,
CEG, and CEL from M17, IPSC cells, and mouse tissue

when using Shapiro–Wilk instead of D'Agostino and Pearson tests.
We note that the Shapiro–Wilk test performs less well with tied
values, perhaps explaining this result. No outliers were detected.
Comparisons between various groups were performed using two-

All analytical measurements were not blinded to M17 cell line

way ANOVA with Tukey's multiple comparisons test and an alpha

(Control vs. DJ-1 shRNA), genotype of IPSC cells, or genotype of

value of 0.05 as implemented in Prism 9.3.0 (GraphPad software).

mice or primary neurons derived from these animals. Standards

ANOVA is robust to modest deviations from normality and was

were synthesized as previously described (Shuck et al., 2018). CEL-

therefore appropriate for analysis of these data.

d4 standard was obtained from Santa Cruz Biotechnology (catalog
number sc219424). CEL was obtained from Abcam (catalog number ab145095). DNA and RNA were isolated as described above,
spiked with 5 ng/ml

15

N5-CEdG or

15

N5-CEG and digested as pre-

viously described (Jaramillo et al., 2017). Protein was isolated as
described above and up to 50 μg of protein per sample was spiked

3
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3.1 | DJ-1 deglycates only reversible guanine-MG
adducts

with 5 ng/ml of CEL-d4 and Lys-d4. Samples were incubated in 6 M
HCl for 18 h at 110°C and then dried under nitrogen with incuba-

DJ-1 and its homologs have been reported to deglycate a range of MG

tion at 80°C, resuspended in 50 μl 0.5% HFBA, and then analyzed

adducts including lysine residues in proteins (Richarme et al., 2015)

using LC–MS/MS. CEdG and CEG were analyzed by injection onto

and guanine bases in DNA and RNA (Richarme et al., 2017)

an Agilent Zorbax SB-C18 column (2.1 × 50 mm, 1.8 μm) with mobile

(Figure 1a). While the role of DJ-1 on glycated amino acids have

phases A: H2O + 0.1% formic acid and B: acetonitrile +0.1% formic

been studied by several groups with conflicting results (Andreeva

acid at 0.4 ml/min. The following gradient was used to separate an-

et al., 2019; Jun & Kool, 2020; Pfaff et al., 2017; Richarme et al., 2015;

alytes: 3%–10% B from 0–4.5 min, 10%–97% B from 4.5–4.8 min,

Richarme et al., 2018; Richarme & Dairou, 2017), DJ-1's influence on

97% B from 4.8 to 5.2 min, and 97% to 3% B from 5.2 to 5.7 min.

nucleotide glycation has been less studied (Richarme et al., 2017).

CEL was analyzed on this same column with an isocratic flow of 10%

We investigated the role of DJ-1 in reversing MG-modified gua-

ACN + 0.1% formic acid at 0.2 ml/min. The following mass transi-

nine nucleosides because this reaction has been proposed to play

tions were monitored: CEdG m/z 340 to 224, 15N5-CEdG m/z 345 to

229, CEG m/z 356 to 224, and 15N5-CEG m/z 361 to 229. CEL m/z 219

an essential role in maintaining genomic integrity in several organisms (Richarme et al., 2017). MG glycation of deoxyguanosine (dG)

to 130 CEL-d4 m/z 223–134, Lys m/z 147–8 4, and Lys-d4 m/z 151 to

in DNA can form either a reversible 1,N2 -(1,2-dihydroxy-2-methyl)

88. Analytes were quantified by fitting to a standard curve and the

ethano-2′-dG (cMG-dG) adduct or irreversible N2 -(1-carboxyethyl)-

normalization to dG or guanosine (measured as described below), or

2′-dG (CEdG) adduct via Schiff base formation and hydrolysis of an

lysine, as appropriate.

initial cMG-dG adduct (Figure 1b). In situations where high concentrations of MG are present, CEdG can be further glycated to the

2.13 | HPLC quantitation of dG and guanosine

stable MG-CEdG adduct (Figure 1b). Glycation of RNA forms the
corresponding guanosine adducts. The ability of recombinant DJ-1
to catalyze the deglycation of various guanine adducts was tested

Following mass spectrometric quantitation of CEdG and CEG, dG

by mixing DJ-1 with a pre-equilibrated mixture of MG and dG and

and guanosine were quantified on an Agilent 1100 HPLC using an

analyzing the resulting products by HPLC and mass spectrometry.

Atlantis T3 column 4.6 × 150 mm, 5 μm. The mobile phases were

We used MG purified by vacuum distillation (see Methods), as the

A: H2O + 0.1% formic acid and B: ACN + 0.1% formic acid with a

purity of commercial MG is low (Shuck et al., 2018). The addition

flow rate of 0.426 ml/min. The following gradient was used: 0–9%

of DJ-1 at the beginning of the reaction prevents formation of both

B, 0–20 min; 9–9.5% B, 20–55 min; 9.5%–90% B, 55–60 min and hold

reversible (cMG-dG) and irreversible (CEdG, MG-CEdG) adducts

60–70 min. 90%–0% B, 70–75 min; 0% B, 75–8 0 min. The area under

more effectively than when MG and dG are incubated together for

the curve was manually integrated and then fit to a standard curve

1 h before DJ-1 addition (Figure 2a; Figure S2). This reduction in MG

to determine dG or G concentration.

adducts requires the catalytic nucleophile C106, as the C106S DJ-1
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F I G U R E 1 Adduct species generated by methylglyoxal (MG). (a) Shows the hydration equilibrium reaction of MG (red), which lies to the
right in aqueous solution. MG can form stable adducts with both guanine and lysine. (b) Shows abbreviated mechanisms for MG modification
of deoxyguanosine to form three adducts. Only cMG-dG is reversible, as indicated.

mutation abrogates this effect (Figure 2b; Figure S2). In contrast to

In aggregate, these findings are consistent with DJ-1 acting on free

DJ-1's ability to prevent the formation of MG adducts when added

MG as the primary substrate, which indirectly reduces the level of

early, incubation of purified R-CEdG and DJ-1 shows no change in

only the reversible MG-nucleoside adducts.

R-CEdG chromatographic retention time on a C18 reverse phase column (Shuck et al., 2018), indicating that this irreversible adduct is not
a substrate for DJ-1 (Figure 2c).
By definition, reversible adducts of MG are in equilibrium with

3.2 | DJ-1 has weak glyoxalase and apparent
deglycase activities in vitro

free MG. Our observations suggest that DJ-1 may act on free MG
directly rather than on the early adducts of MG and guanine. If true,

Measurement of the putative deglycase activity of DJ-1 has pro-

this predicts that a similar reduction of only the reversible MG ad-

duced variable and contradictory results, although the groups

ducts should be observed when small molecule aldehyde scavengers

measuring this activity have used a similar in vitro protocols (Pfaff

are added. We confirmed this by adding the aldehyde-reactive com-

et al., 2017; Richarme et al., 2015; Richarme & Dairou, 2017; Witt

pounds DNPH and aminoguanidine, which behave similarly to DJ-1

et al., 2008). We measured the apparent deglycase activity of DJ-1

in reducing the levels of reversible MG adducts with dG (Figure S3)

using a well-established assay that follows the decay of the 288 nm

and form adducts with DNPH described in (Gilbert & Brandt, 1975).

absorbance of the reversible hemithioacetal formed by incubation of
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hemithioacetal substrates, the apparent kcat values were ~0.007–
0.009 s−1 and KM values were ~60–150 μM (Table 1). These activities

are markedly lower than some previously reported values (Richarme
et al., 2015). DJ-1 apparent deglycase catalytic efficiency (kcat/KM)

values are ~50–100 M−1 s−1, approximately 1 × 105 fold lower than

that of glyoxalase 1 acting on GSH-MG hemithioacetal as substrate
(1.2 × 107 M−1 s−1 for E. coli GlxI) (Clugston et al., 1998).
The reactive Cys106 residue is the presumed catalytic nucleophile in human DJ-1. We confirmed that DJ-1's ability to consume
MG-NAC hemithioacetal is Cys106-dependent by showing that neither the C106S mutant nor the Cys106-sulfinate (C106-SO2−) oxidized form of the protein has significant apparent deglycase activity
(Figure 3c). The active site environment of Cys106 features a protonated Glu18 residue that makes a hydrogen bond to the Cys106 thiolate (Witt et al., 2008) and was identified as catalytically important in
prior reports of DJ-1 glyoxalase activity (Lee et al., 2012). Consistent
with these prior reports, mutations at the nearby protonated Glu18
ablated DJ-1-mediated consumption of MG-NAC hemithioacetal
(Figure 3c). Our prior structural studies showed that E18D, E18N,
and wild-t ype DJ-1 have nearly identical crystal structures and that
Glu18 mutations only slightly perturb the steric environment of
Cys106 (Blackinton et al., 2009; Witt et al., 2008), suggesting that
these mutations do not eliminate DJ-1's apparent deglycation activity via major changes in protein structure. Instead, it is likely that
mutations at Glu18 remove an important general acid/base in the
proposed DJ-1 glyoxalase mechanism (Figure S4).
Because hemithioacetals are obligatorily reversible MG adducts that cannot be converted to irreversible glycated products
via the Amadori rearrangement, they always exist in equilibrium
F I G U R E 2 DJ-1 can only repair reversible adducts of MG and
guanine in vitro. (a) the addition of DJ-1 at the same time as MG
and dG (+DJ-1 beginning; blue) reduces levels of both reversible
cMG-dG and irreversible MG-CEdG adducts, while the addition of
DJ-1 after 1 h of preincubation of MG and dG (+DJ-1; white) results
in an accumulation of irreversible MG-CEdG and cannot restore
unmodified dG. (b) the C106S mutant (cyan), which removes the
catalytic thiolate nucleophile, is inactive and cannot prevent dG
modification. Only catalytically active DJ-1 prevents the formation
of dG adducts when added at the same time as MG. (c) the addition
of DJ-1 results in no change in the HPLC retention time of purified
CEdG, an irreversible adduct. In all panels, each measurement is
shown as a circle with a standard error of the mean shown in error
bars.

with free MG. Therefore, DJ-1's apparent deglycation activity may
be because of its action on free MG, as we proposed above for
guanine MG adducts and was also proposed by others for other
reversible MG adducts (Andreeva et al., 2019). DJ-1 has an established glyoxalase activity, although estimates for its kinetic
parameters have varied widely (Andreeva et al., 2019; Choi, Kim,
et al., 2014; Hasim et al., 2014; Lee et al., 2012; Pfaff et al., 2017;
Richarme et al., 2015). Unlike some other glyoxalases in the DJ-1
superfamily, several studies indicate that human DJ-1 produces
exclusively L-lactate as a product when acting on MG (Choi, Kim,
et al., 2014; Hasim et al., 2014), although one report indicates that
DJ-1 produces a minor fraction of D-lactate when acting on MG-
NAC hemithioacetal (Richarme et al., 2015). The dominant production of L-lactate allows us to measure DJ-1 catalytic activity

MG with free thiols (Lo et al., 1994)(Figure 3a). MG-hemithioacetals

using an L-lactate-coupled assay. We measured the rate at which

were formed by reaction of MG with NAC, GSH, or CoA (see

DJ-1 converts MG to L-lactate in real time using L-lactate oxidase,

Methods). NAC is a standard model thiol, GSH is the most abundant

horseradish peroxidase, and resorufin in a coupled assay that is

small molecule thiol in the cell, and CoA has been used previously

similar to one used previously (Andreeva et al., 2019). Varying

as a physiologically relevant thiol whose glycation DJ-1 can reduce

the concentration of the coupling enzymes L-lactate oxidase

(Matsuda et al., 2017). Tris-containing buffers were not used to avoid

and horseradish peroxidase has little effect on the initial rate

previously reported buffer artifacts (Pfaff et al., 2017). The addition

measurements, confirming that DJ-1's activity is rate-limiting in

of DJ-1 reduces the concentrations of each of these three hemith-

this coupled assay. DJ-1's glyoxalase activity is well-f itted using

ioacetals with initial steady-state rates that are well-fitted using

the Michaelis–M enten model (Figure 3d) and produces kinetic

the Michaelis–Menten kinetics model (Figure 3b,c). For the three

constants (Table 1) which are in reasonable agreement with the
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F I G U R E 3 DJ-1 has apparent hemithioacetal deglycase and glyoxalase activities in vitro. (a) Mechanism of formation of hemithioacetal
formation by NAC (black) and MG (red). The hemithioacetal is reversible, as indicated by the arrows. (b) Steady-state enzyme kinetics of
DJ-1 acting on the MG-glutathione (MG-GSH; red) and MG-coenzyme a (MG-CoA; black) hemitioacetal substrates. (c) Steady-state kinetics
of DJ-1 acting on the MG-N-acetyl cysteine (MG-NAC) hemithioacetal (HTA) substrate. Wild-t ype (WT) enzyme is in red, and mutants and
oxidative modification are shown in the inset legend with the indicated symbols and colors. Only WT DJ-1 is active enough to be reliably
fitted using the Michaelis–Menten model (solid lines). (d) Steady-state kinetics of DJ-1 glyoxalase activity against MG as substrate. In panels
(b–d), initial velocity (V0) is divided by total enzyme concentration ([Et]) on the Y-axis, rates were measured a minimum of three times with
standard deviation shown in bars, and the fitted Michaelis–Menten curves are shown as solid lines.

kcat ~ 0.02 s−1 reported by Andreeva et al. (Andreeva et al., 2019).

need for a DJ-1 deglycase activity (Figure 4a). The modeled ki-

DJ-1's glyoxalase kcat is ~10-fold greater than its apparent degly-

netic parameters for DJ-1 glyoxalase activity also agree well with

case kcat .

the measured glyoxalase activity progress curves of the enzyme
(Figure 4b) and produce glyoxalase kcat and K m values that agree

3.3 | Kinetic modeling indicates that DJ-1
glyoxalase activity is sufficient to explain its apparent
deglycase activity

well with the experimentally determined ones (Table 2). The ability to fit the data in Figure 4 without needing to invoke a postulated DJ-1 deglycase activity supports the conclusion (Andreeva
et al., 2019) that DJ-1 is not a primary deglycase but reduces the
concentrations of reversible MG adducts through its action on MG

To determine if the low apparent deglycase activity for DJ-1 could

and the equilibria in Scheme 1.

be explained by its higher glyoxalase activity, we used kinetic modeling. We simulated the DJ-1-catalyzed glyoxalase reaction using a
simple Michaelis–Menten mechanism (reaction 1) coupled to hemiothioacetal production via the reaction of methylglyoxal with N-

3.4 | DJ-1 reduces total protein and nucleic acid
glycation burden in cultured neuronal cells and mice

acetylcysteine (Scheme 1).
The measured progress curve for DJ-1-m ediated loss of

DJ-1's contribution to reducing the overall glycation burden in cells

NAC-M G hemithioacetal can be adequately modeled using a ki-

is contentious, with some studies indicating major effects (Richarme

netic scheme that includes only a glyoxalase activity for DJ-1 and

et al., 2015; Richarme et al., 2017; Sharma et al., 2019) and others

an equilibrium of free MG and MG-N AC hemithioacetal, without

detecting no changes (Andreeva et al., 2019; Pfaff et al., 2017). In
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these studies, protein glycation has been measured primarily using

Figure S1) and observed a trend of increased CEdG, CEG, and CEL

western blotting. Western-based detection of glycated macromol-

levels when DJ-1 levels are decreased, although these effects are

ecules is complicated by the need for specific antibodies against the

small (Figure 5a).

modification of interest and the difficulty of quantifying the blots.

Although M17 cells are biochemically similar to the vulnerable

To address these limitations, we used quantitative isotope dilution

neurons in Parkinson's Disease, they are immortalized and thus have

mass spectrometry with internal 15N5-CEdG,15N5-CEG, CEL-d4, and

potential alterations in metabolism that could affect glycation. To

Lys-d4 standards for quantifying glycated guanine in DNA, RNA,

address this, we also measured glycated products in two distinct

and glycated lysine in proteins. Using dopaminergic M17 neuro-

neuronal lineages: induced pluripotent stem cell-derived forebrain

blastoma cells, we knocked down DJ-1 using shRNA (see Methods,

neurons created from fibroblasts donated by a patient bearing a
A111L missense mutation that eliminates steady-state DJ-1 (Mazza

TA B L E 1 DJ-1 kinetic parameters from experiment
−1

et al., 2021) and primary neurons cultured from DJ-1−/− mice. In both
kcat/KM
(M−1 s−1)

Substrate

kcat (s )

KM (M)

MG

7.3(2) × 10−2

3.47(34) × 10 −4

210

−3

−5

150

5.80(11) × 10

MG-NAC

8.7(3) × 10

MG-GSH

6.7(3) × 10 −3

1.42(28) × 10 −4

47

MG-CoA

6.8(7) × 10 −3

1.44(64) × 10 −4

47

DJ-1-deficient neuronal cultures, glycation products are slightly elevated (Figure 5a–c), although this increase only reaches the p < 0.05
significance threshold for CEL in M17 cells and CEG in iPSC-derived
neurons (Figure 5a,b). A similar effect is seen in overall mouse brain
tissue, where DJ-1 knockout elevates all three classes of glycated
products by 1–2 modified species/106 unmodified, which is statistically significant for CEG and CEL (Figure S5).

F I G U R E 4 Kinetic simulation of DJ-1 deglycase and glyoxalase activities. (a) Experimental progress curves for loss of MG-NAC
hemithioacetal signal at 288 nm (colored dots) are superimposed with kinetic modeling results (solid lines) for various concentrations of total
MG concentration at initial dilution. The simulation requires only a DJ-1 glyoxalase activity to produce good fits to the apparent deglycase
activity. (b) Experimentally measured DJ-1 glyoxalase activity against various concentrations of MG (colored dots) is well-modeled by the
kinetic simulation (solid lines) whose rate constants also explain the apparent deglycase activities in (a).
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The glutathione-dependent glyoxalase I/II (GloI/II) system is the

cysteine ligase, the rate-limiting enzyme in glutathione (GSH) bio-

primary means for detoxifying MG in the cell. Because the in vitro

synthesis (Griffith & Meister, 1979). As GSH is a co-substrate for

catalytic rate of GloI is several orders of magnitude greater than

GloI, reduction in the GSH pool should reduce GloI activity in cells.

that of DJ-1, it is possible that DJ-1 would make a larger contribu-

BSO administration to M17 neuroblastoma cells markedly increases

tion to glycation defense when the GloI/II is impaired. We tested

CEL levels when compared with vehicle alone, although the effect

this using buthionine sulfoximine (BSO), an inhibitor of γ-glutamyl

on CEG and CEdG levels is not significant. When BSO is applied to
DJ-1 knockdown cells, it leads to significant increases in all three

TA B L E 2 DJ-1 kinetic parameters with MG substrate from
kinetic simulation
Rate constant
k1 (M

−1 −1

s )

k−1 (s−1)
−1

k2 (kcat ) (s )
b

Calculated KM
(M)

k3 (M−1 s−1)
−1

k−3 (s )

a

a

Best-fit value

Lower
boundary

360

123.83

11466.67

7.82 × 10 −2

2.62 × 10 −12

4.02 × 10

−2

3.82 × 10

3.29 × 10

−4

c

3.25
6.5 × 10

−3

Upper
boundary

−2

2.76 × 10

c

3.63 × 10 −4

3.5 | DJ-1 does not protect cells against
MG toxicity

104.17

DJ-1 decreases total cellular CEdG, CEG, and CEL levels in some in-

d

stances, although the absolute magnitude of this decrement is rela-

ND

The KM was calculated using the definition Km =

ND

k−1 + k2
k1

.

Lower and upper boundaries are not determined directly in KinTek
global software for steady-state constants therefore they were
calculated from the collection of rate constants that fit the data within
a 0.83 relative error from the best-fit.
d

pared to DJ-1's weaker glyoxalase activity.

1.98

Lower and upper boundaries were determined by a published
algorithm that varies the rate constants to find values that fall within a
0.83 relative error to the best-fit (82).
(
)

c

when BSO is applied to DJ-1 knockdown cells suggests that Glo1's
stronger glyoxalase activity dominates the cellular MG defense com-

d

a

b

most pronounced for CEL (Figure 6c). The enhancement of glycation

4.13
4.27 × 10 −2

−4

glycated metabolites (CEdG, CEG, and CEL) and this effect is again

KinTek global explorer software only estimates one rate constant when
the ratio is being constrained by the equilibrium constant (500 M−1).

tively small (~1–2 glycated products/106 unmodified). To determine if
this reduction in glycation corresponds to increased cellular protection
against MG toxicity by DJ-1, we measured the effect of DJ-1 on the
survival of both M17 neuroblastoma cells and iPSC-derived neurons in
10–10 000 μM exogenously added MG. M17 cells show a clear loss of
viability with an IC50 of 809.2 μM MG, but DJ-1 siRNA knockdown has
no effect on cell survival (Figure 7). Sensitization to MG, resulting in a
decrease of IC50, would be expected if DJ-1 made a significant contribution to cellular viability during MG challenge of these cells. Neurons

F I G U R E 5 DJ-1 has a modest impact on cellular concentrations of irreversible glycation products in neurons. In all panels, isotope-
dilution mass spectrometry was used to obtain relative concentrations of modified versus unmodified dG, G, or Lys. Replicate independent
culture sample is shown as a circle with standard error of the mean shown in error bars (n = 4–9 independent cultures as indicated). Two-way
ANOVA with multiple comparisons was used for statistical analysis with Tukey's honest significant post hoc test for individual comparisons
with p-values indicated. Detailed two-way ANOVA values are shown in Tables S3–S5. Small but consistent elevations in glycated products
were observed in (a) shRNA knockdown of DJ-1 in immortalized M17 neuroblastoma, (b) iPSC-derived neurons derived from wild-t ype
(WT) cells and cell bearing a DJ-1 missense mutation that eliminates protein (DJ-1 p.Ala111Leufs*7), and (c) primary neurons from WT and
DJ-1−/− mice. Each replicate's independent culture sample is shown as a circle with standard error of the mean shown in error bars (n = 4–9
independent cultures as indicated).
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derived from iPSCs show no loss of viability across a 10–1000 μM MG

lower than the average enzyme kcat value (Bar-Even et al., 2011),

range, and the inactivating A111L DJ-1 mutation does not sensitize

but is still 10x higher than the maximal rate of DJ-1's apparent

them to MG (Figure 7). These negative results are consistent with prior

deglycase activity. There has been disagreement in the litera-

reports that loss of DJ-1 has no effect on MG sensitivity in Drosophila

ture about kinetic constants for DJ-1's glyoxalase activity (Jun &

and HEK293 cells (Andreeva et al., 2019; Pfaff et al., 2017).

Kool, 2020), and we note that our results agree reasonably well
with those of Andreeva et al. measured in a similar buffer (Andreeva

4
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DISCUSSION

et al., 2019). We observe that DJ-1 can only reduce the levels of
freely reversible MG adducts in vitro, and our kinetic modeling
shows that DJ-1's glyoxalase activity is sufficient to explain its ap-

DJ-1 defends multiple types of cells against oxidative stress and mi-

parent activity on MG adducts. Here again, these new quantita-

tochondrial damage. One model of DJ-1-mediated cytoprotection

tive kinetic modeling results support the conclusions of Andreeva

is that it is a redox-responsive protein that uses cysteine oxidation

et al. (Andreeva et al., 2019) that the apparent deglycase activity

to sense changes in redox homeostasis and enhances cell survival

of DJ-1 is likely because of its action on free MG regardless of the

through the PTEN/Akt (Kim et al., 2005), Nrf2 (Bahmed et al., 2016;

reversibly glycated species: aminocarbinol, hemithioacetal, cyclic

Clements et al., 2006), and ASK1 (Cao et al., 2014; Waak et al., 2009)

dihydroimidazolone, or others. This conclusion contradicts several

signaling pathways. However, DJ-1 has more recently been reported

reports from the Richarme group (Richarme et al., 2015; Richarme

to have Cys106-dependent glyoxalase and deglycase activities, in-

et al., 2017; Richarme et al., 2018; Richarme & Dairou, 2017) but

dicating that the protein may also play important roles in defense

is chemically sensible, as there is no clear mechanism by which

against reactive carbonyl species such as MG. DJ-1's glyoxalase ac-

a cysteine nucleophile-d ependent enzyme could deglycate these

tivity is widely corroborated, although it is significantly less efficient

diverse species, all of which lack a plausible electrophilic center

than Glo1 and there is considerable disagreement regarding DJ-1's

for Cys106 thiolate attack. In addition, we find that both the E18N

kinetic constants. The deglycase activity for DJ-1 is more contro-

and E18D mutants eliminate DJ-1's ability to revert reversibly gly-

versial, with some groups reporting that it is either an artifact (Pfaff

cated species, consistent with some prior reports (Lee et al., 2012;

et al., 2017) or an apparent activity of DJ-1 acting on methylglyoxal

Matsuda et al., 2017) and demonstrating that Glu18 is catalytically

(Andreeva et al., 2019), while others report that deglycation is the

essential for DJ-1 glyoxalase activity. Considering these results in

most important activity of DJ-1 (Richarme et al., 2015; Richarme

the context of the DJ-1 crystal structure, we propose a mechanism

et al., 2017).

where the protonated Glu18 is the general acid that protonates

Our results help resolve this dispute, as we find that DJ-1 is a
weak glyoxalase with a kcat ~ 0.07 s−1 in PBS buffer. This is ~100x

the oxyanion formed upon Cys106 attack at the electrophilic aldehyde carbon atom of MG (Figure S4).

F I G U R E 6 Chemical reduction in cellular glutathione enhances the glycation burden of DJ-1 knockdown M17 cells. In all panels, isotope-
dilution mass spectrometry was used to obtain relative concentrations of modified versus unmodified dG, G, or Lys in cultured M17
neuroblastoma cells. Two-way ANOVA with multiple comparisons was used for statistical analysis with Tukey's honest significant post hoc
test for individual comparisons with p-values indicated. Detailed two-way ANOVA values are shown in Tables S6–S8. BSO was used to
reduce cellular levels of GSH, which is a co-substrate for the dominant glyoxalase Glo1. Administration of BSO enhances the effect of DJ-1
deficiency on CEdG (a), CEG (b), and CEL (c) levels. Replicate independent culture sample is shown as a circle with standard error of the mean
shown in error bars (n = 4 independent cultures per cell line and treatment).

|

MAZZA et al.

257

catalytic nucleophile will be abrogated by oxidation of Cys106 that
occurs during oxidative stress, suggesting that DJ-1's known enzymatic and redox-sensing protective mechanisms are orthogonal and
require different cellular pools of the protein.
The low catalytic efficiency of DJ-1's glyoxalase activity
(kcat/KM = 210 M−1 s−1) raises questions about its physiological rel-

evance, as it is much lower than the ~107 M−1 s−1 kcat/KM of Glo1

(Clugston et al., 1998; Inoue & Kimura, 1996). Glo1, a highly conserved and widely expressed enzyme that converts the MG-
glutathione hemithioacetal to S-lactoylglutathione, is the dominant
mechanism of MG detoxification in most cells. It seems implausible that DJ-1 could contribute significantly to the cellular defense
against MG against a background of more catalytically proficient
Glo1 unless Glo1 activity is diminished by glutathione depletion or
other mechanisms. Despite these considerations, we find using sensitive and quantitative isotope dilution mass spectrometry that the
absence of DJ-1 results in small elevations in neuronal CEdG, CEG,
and CEL, three surrogate biomarkers for MG reaction with DNA,
RNA, and protein, respectively. These elevated levels are found in
immortalized M17 neuroblastoma cells, iPSC-derived neurons, primary mouse neurons, and whole mouse brain, establishing that this
is observed across multiple neuronal types. Moreover, the effect is
observed both in vivo and under standard cell culture conditions
without external (and unphysiological) administration of bolus MG.
Although the effect size is modest, it is nonetheless surprising given
the low catalytic activity of DJ-1. We offer two speculative hypotheses that may explain this result. First, DJ-1 may have substantially
greater glyoxalase activity in the cell than observed in vitro using recombinant protein, perhaps owing to the presence of yet-unknown
modifications or regulators in the cell that enhance its activity. This
explanation may seem contrived, however this effect has been observed for the related Hsp31 glyoxalase in Saccharomyces cerevisiae, although the cause of endogenous Hsp31's enhanced activity
remains unknown (Aslam & Hazbun, 2016). Further supporting the
sensitivity of DJ-1's glyoxalase activity to the details of the solution
reaction environment, the in vitro DJ-1 glyoxalase activity is markedly higher in phosphate buffer than in PBS (Mulikova et al., 2021).
Second, it is possible that DJ-1's glyoxalase activity is not directly
F I G U R E 7 DJ-1 deficiency does not enhance cell death in the
presence of exogenous MG. Exogenous MG was added to cultured
M17 cells (a) and iPSC-derived neurons (b). No enhancement of cell
death was observed when DJ-1 was knocked down with shRNA
(a) or absent at the protein level because of mutation (b) (n = 6
replicate cultures per cell line and treatment).

responsible for its ability to reduce cellular glycation burden. In this
model, DJ-1 would enhance the activities of other pathways that are
more effective at reducing steady-state levels of MG. This model
could be tested using mutations such as E18N that eliminate DJ-1
glyoxalase activity but preserve its protective activity against oxidative and mitochondrial damage stressors and warrant further
investigation.

Prior studies show that E18N and E18Q DJ-1 can protect cells

DJ-1 does not improve cellular viability against MG toxicity

from mitochondrial damage induced by rotenone, preserve nor-

in our experiments, supporting some prior reports (Andreeva

mal mitochondrial morphology (Blackinton et al., 2009), and are

et al., 2019; Pfaff et al., 2017) while contradicting others (Lee

functional in other assays of DJ-1 activity (Cao et al., 2014; Xu

et al., 2012; Richarme et al., 2015). It is possible that DJ-1's modest

et al., 2018). These results indicate that aspects of DJ-1 cytoprotec-

ability to reduce glycation may be more important for the survival

tion related to oxidative stress response and mitochondrial dysfunc-

of certain types of cells, although the studies reporting nega-

tion are not explained by DJ-1's glyoxalase activity. Furthermore,

tive results used human and mouse neurons (this work), HEK293

any cytoprotective enzymatic activity that requires Cys106 as the

cells (Andreeva et al., 2019), Drosophila (Pfaff et al., 2017),
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ectopic expression of DJ-1 in Glo1-d eficient S. cerevisiae (Natkanska

AC K N OW L E D G M E N T S

et al., 2017), and S. pombe (Zhao et al., 2014). The yeast studies are

We thank Dr. Javier Seravalli (Redox Biology Center Mass

informative, as they show that over-expressed human or S. pombe

Spectrometry Core Facility, University of Nebraska) for assistance

DJ-1 does not rescue the greatly increased sensitivity to exoge-

with mass spectrometry of recombinant DJ-1. This research was sup-

nous MG that results from knockout of Glo1. By contrast, these

ported in part by the Intramural Research Program of the National

same studies showed that Hsp31 proteins, which are more active

Institutes of Health (NIH), National Institute on Aging. MAW ac-

glutathione-independent glyoxalases from a different clade of the

knowledges support from NIH R01GM139978 and JT acknowledges

DJ-1 superfamily, can rescue the viability of Glo1-d eficient yeasts

R01CA176611. Work performed in the Mass Spectrometry Shared

(Natkanska et al., 2017; Zhao et al., 2014). Hsp31 has a kcat /K M for

Resource at City of Hope is supported by the National Cancer

MG of ~10 –10 M

3

4

−1 −1

s , which is 10–100-fold higher than DJ-1 but

Institute of the National Institute of Health under award number

still 1000–10 000-fold lower than Glo1. Therefore, the ability of

P30 CA033572. Mark Cookson is a former Senior Editor of the

Hsp31 to rescue MG sensitivity in ΔGLO1 yeast shows that these

Journal of Neurochemistry. Open access funding enabled and or-

complementation experiments are sensitive enough to detect

ganized by ProjektDEAL.

glyoxalase activities that are several orders of magnitude lower
than Glo1. In light of our present results and prior independent

C O N FL I C T O F I N T E R E S T

negative reports, DJ-1's glyoxalase activity does not appear to be

The other authors declare no conflicts of interest that would affect

physiologically relevant for overall cell viability when challenged

the objectivity of this study.

with exogenous MG. Our results do not directly address a potential role for DJ-1 in protecting specific proteins from glycation,

DATA AVA I L A B I L I T Y S TAT E M E N T

which has been reported for histones (Galligan et al., 2018; Zheng

The data that support the findings of this study are available from

et al., 2019). It is speculatively possible that DJ-1's weak glyoxalase

the corresponding author upon reasonable request. A preprint of

activity may be especially important for sensitive proteins or spe-

this article was posted on February 19th, 2022 on BioRxiv: https://

cific cellular compartments that are not addressed in this global

www.biorxiv.org/content/10.1101/2022.02.18.481064v2

study of cellular glycation.
Very recently, DJ-1 and its close homologs were shown to

ORCID

strongly protect proteins and metabolites against glycerate and

Mark R. Cookson

phosphoglycerate modifications (Heremans et al., 2022). In that

Mark A. Wilson

https://orcid.org/0000-0002-1058-3831
https://orcid.org/0000-0001-6317-900X

study, DJ-1 was proposed to use Cys106 to open a reactive cyclic
1,3 phosphoglycerate metabolite that may be spontaneously formed

REFERENCES

from 1,3 bisphosphoglycerate (i.e., DJ-1 is a cyclic 1,3 phosphoglyc-

Andreeva, A., Bekkhozhin, Z., Omertassova, N., Baizhumanov, T., Yeltay,
G., Akhmetali, M., Toibazar, D., & Utepbergenov, D. (2019). The
apparent deglycase activity of DJ-1 results from the conversion
of free methylglyoxal present in fast equilibrium with hemithioacetals and hemiaminals. The Journal of Biological Chemistry, 294,
18863–18872.
Andres-Mateos, E., Perier, C., Zhang, L., Blanchard-Fillion, B., Greco, T.
M., Thomas, B., Ko, H. S., Sasaki, M., Ischiropoulos, H., Przedborski,
S., Dawson, T. M., & Dawson, V. L. (2007). DJ-1 gene deletion reveals
that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proceedings
of the National Academy of Sciences of the United States of America,
104, 14807–14812.
Aslam, K., & Hazbun, T. R. (2016). Hsp31, a member of the DJ-1 superfamily, is a multitasking stress responder with chaperone activity.
Prion, 10, 103–111.
Atieh, T. B., Roth, J., Yang, X., Hoop, C. L., & Baum, J. (2021). DJ-1 acts as
a scavenger of alpha-synuclein oligomers and restores monomeric
glycated alpha-synuclein. Biomolecules, 11, 1466.
Bahmed, K., Boukhenouna, S., Karim, L., Andrews, T., Lin, J., Powers, R.,
Wilson, M. A., Lin, C. R., Messier, E., Reisdorph, N., Powell, R. L.,
Tang, H. Y., Mason, R. J., Criner, G. J., & Kosmider, B. (2019). The
effect of cysteine oxidation on DJ-1 cytoprotective function in
human alveolar type II cells. Cell Death & Disease, 10, 638.
Bahmed, K., Messier, E. M., Zhou, W., Tuder, R. M., Freed, C. R., Chu,
H. W., Kelsen, S. G., Bowler, R. P., Mason, R. J., & Kosmider, B.
(2016). DJ-1 modulates nuclear erythroid 2-related Factor-2-
mediated protection in human primary alveolar type II cells
in smokers. American Journal of Respiratory Cell and Molecular
Biology, 55, 439–4 49.

erate phosphodiesterase). This enzymatic activity is difficult to directly assay owing to the instability of the presumptive substrate
so we did not investigate it in this study. However, we note that
such an activity may provide a functional explanation for the tendency of the Arg28/Arg48 motif near the DJ-1 active site to bind
tetrahedral anions (Witt et al., 2008). The presence of this anion-
binding di-arginine motif is more consistent with DJ-1 acting on a
phosphate-containing substrate than with MG being its primary substrate. As we discussed above for DJ-1 glyoxalase activity, mutation
of Glu18 could be used to interrogate the importance of a DJ-1 cyclic
1,3 phosphoglycerate phosphodiesterase activity relative to other
potential roles of oxidized isoforms of the protein, which we predict
would be affected differently by E18N/D/Q mutations. Finally, it is
intriguing (though possibly coincidental) that both glyoxalase and cyclic 1,3 phosphoglycerate phosphodiesterase activities act on triose
phosphate-derived metabolites resulting from glycolysis, which is
restricted to the cytosol in eukaryotic cells.
AU T H O R C O N T R I B U T I O N S
J.T., M.R.C., and M.A.W. conceived the study, M.A.M, J.L., S.C.S., and
M.C.M. designed and performed experiments. M.A.M, J.L., S.C.S.,
M.C.M., M.R.C., J.T., and M.A.W. analyzed the data and wrote the
manuscript.

MAZZA et al.

Bandyopadhyay, S., & Cookson, M. R. (2004). Evolutionary and functional relationships within the DJ1 superfamily. BMC Evolutionary
Biology, 4, 6.
Bar-Even, A., Noor, E., Savir, Y., Liebermeister, W., Davidi, D., Tawfik,
D. S., & Milo, R. (2011). The moderately efficient enzyme:
Evolutionary and physicochemical trends shaping enzyme parameters. Biochemistry, 50, 4402–4 410.
Blackinton, J., Lakshminarasimhan, M., Thomas, K. J., Ahmad, R., Greggio,
E., Raza, A. S., Cookson, M. R., & Wilson, M. A. (2009). Formation
of a stabilized cysteine sulfinic acid is critical for the mitochondrial
function of the parkinsonism protein DJ-1. The Journal of Biological
Chemistry, 284, 6476–6 485.
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J.,
Krieger, E., Dekker, M. C., Squitieri, F., Ibanez, P., Joosse, M., van
Dongen, J. W., Vanacore, N., Swieten, J. C., Brice, A., Meco, G., van
Duijn, C. M., Oostra, B. A., & Heutink, P. (2003). Mutations in the
DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science, 299, 256–259.
Cali, T., Ottolini, D., Soriano, M. E., & Brini, M. (2015). A new split-GFP-
based probe reveals DJ-1 translocation into the mitochondrial
matrix to sustain ATP synthesis upon nutrient deprivation. Human
Molecular Genetics, 24, 1045–1060.
Canet-Aviles, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon,
C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., &
Cookson, M. R. (2004). The Parkinson's disease protein DJ-1 is
neuroprotective due to cysteine-sulfinic acid-driven mitochondrial
localization. Proceedings of the National Academy of Sciences of the
United States of America, 101, 9103–9108.
Cao, J., Chen, X., Ying, M., He, Q., & Yang, B. (2017). DJ-1 as a therapeutic target against cancer. Advances in Experimental Medicine and
Biology, 1037, 203–222.
Cao, J., Ying, M., Xie, N., Lin, G., Dong, R., Zhang, J., Yan, H., Yang, X., He,
Q., & Yang, B. (2014). The oxidation states of DJ-1 dictate the cell
fate in response to oxidative stress triggered by 4-hpr: Autophagy
or apoptosis? Antioxidants & Redox Signaling, 21, 1443–1459.
Chen, J., Li, L., & Chin, L. S. (2010). Parkinson disease protein DJ-1 converts from a zymogen to a protease by carboxyl-terminal cleavage.
Human Molecular Genetics, 19, 2395–2408.
Choi, D., Kim, J., Ha, S., Kwon, K., Kim, E. H., Lee, H. Y., Ryu, K. S., & Park,
C. (2014). Stereospecific mechanism of DJ-1 glyoxalases inferred
from their hemithioacetal-containing crystal structures. The FEBS
Journal, 281, 5447–5462.
Choi, M. S., Nakamura, T., Cho, S. J., Han, X., Holland, E. A., Qu, J., Petsko,
G. A., Yates, J. R. 3rd, Liddington, R. C., & Lipton, S. A. (2014).
Transnitrosylation from DJ-1 to PTEN attenuates neuronal cell
death in parkinson's disease models. The Journal of Neuroscience,
34, 15123–15131.
Clements, C. M., McNally, R. S., Conti, B. J., Mak, T. W., & Ting, J. P.
(2006). DJ-1, a cancer-and Parkinson's disease-associated protein,
stabilizes the antioxidant transcriptional master regulator Nrf2.
Proceedings of the National Academy of Sciences of the United States
of America, 103, 15091–15096.
Clugston, S. L., Barnard, J. F., Kinach, R., Miedema, D., Ruman, R.,
Daub, E., & Honek, J. F. (1998). Overproduction and characterization of a dimeric non-z inc glyoxalase I from Escherichia coli:
Evidence for optimal activation by nickel ions. Biochemistry, 37,
8754–8763.
Cuevas, S., Zhang, Y., Yang, Y., Escano, C., Asico, L., Jones, J. E., Armando,
I., & Jose, P. A. (2012). Role of renal DJ-1 in the pathogenesis of
hypertension associated with increased reactive oxygen species
production. Hypertension, 59, 446–452.
Du, X., Choi, I. G., Kim, R., Wang, W., Jancarik, J., Yokota, H., & Kim,
S. H. (2000). Crystal structure of an intracellular protease from
Pyrococcus horikoshii at 2-a resolution. Proceedings of the
National Academy of Sciences of the United States of America, 97,
14079–14084.

|

259

Eltoweissy, M., Muller, G. A., Bibi, A., Nguye, P. V., Dihazi, G. H., Muller,
C. A., & Dihazi, H. (2011). Proteomics analysis identifies PARK7 as
an important player for renal cell resistance and survival under oxidative stress. Molecular BioSystems, 7, 1277–1288.
Galligan, J. J., Wepy, J. A., Streeter, M. D., Kingsley, P. J., Mitchener, M. M.,
Wauchope, O. R., Beavers, W. N., Rose, K. L., Wang, T., Spiegel, D.
A., & Marnett, L. J. (2018). Methylglyoxal-derived posttranslational
arginine modifications are abundant histone marks. Proceedings of
the National Academy of Sciences of the United States of America, 115,
9228–9233.
Gilbert, R. P., & Brandt, R. B. (1975). Spectrometric determination
of methylglyoxal with 2,4-dinitrophenylhydrazine. Analytical
Chemistry, 47, 2418–2422.
Goda, M., Hashimoto, Y., Shimizu, S., & Kobayashi, M. (2001). Discovery
of a novel enzyme, isonitrile hydratase, involved in nitrogen-c arbon
triple bond cleavage. The Journal of Biological Chemistry, 276,
23480–23485.
Goda, M., Hashimoto, Y., Takase, M., Herai, S., Iwahara, Y., Higashibata,
H., & Kobayashi, M. (2002). Isonitrile hydratase from pseudomonas
putida N19-2. Cloning, sequencing, gene expression, and identification of its active acid residue. The Journal of Biological Chemistry,
277, 45860–45865.
Griffith, O. W., & Meister, A. (1979). Potent and specific inhibition of
glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). The Journal of Biological Chemistry, 254,
7558–7560.
Halio, S. B., Blumentals, I. I., Short, S. A., Merrill, B. M., & Kelly, R. M.
(1996). Sequence, expression in Escherichia coli, and analysis of the
gene encoding a novel intracellular protease (PfpI) from the hyperthermophilic archaeon Pyrococcus furiosus. Journal of Bacteriology,
178, 2605–2612.
Hasim, S., Hussin, N. A., Alomar, F., Bidasee, K. R., Nickerson, K. W., &
Wilson, M. A. (2014). A glutathione-independent glyoxalase of the
DJ-1 superfamily plays an important role in managing metabolically generated methylglyoxal in Candida albicans. The Journal of
Biological Chemistry, 289, 1662–1674.
Heremans, I. P., Caligiore, F., Gerin, I., Bury, M., Lutz, M., Graff, J.,
Stroobant, V., Vertommen, D., Teleman, A. A., Van Schaftingen, E.,
& Bommer, G. T. (2022). Parkinson's disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite. Proceedings of the National Academy of Sciences of The United
States of America, 119, e2111338119.
Hod, Y. (2004). Differential control of apoptosis by DJ-1 in prostate benign and cancer cells. Journal of Cellular Biochemistry, 92,
1221–1233.
Hod, Y., Pentyala, S. N., Whyard, T. C., & El-Maghrabi, M. R. (1999).
Identification and characterization of a novel protein that regulates RNA-protein interaction. Journal of Cellular Biochemistry, 72,
435–4 44.
Inoue, Y., & Kimura, A. (1996). Identification of the structural gene for
glyoxalase I from Saccharomyces cerevisiae. The Journal of Biological
Chemistry, 271, 25958–25965.
Jaramillo, R., Shuck, S. C., Chan, Y. S., Liu, X., Bates, S. E., Lim, P. P., Tamae,
D., Lacoste, S., O'Connor, T. R., & Termini, J. (2017). DNA advanced
glycation end products (DNA-AGEs) are elevated in urine and tissue in an animal model of type 2 diabetes. Chemical Research in
Toxicology, 30, 689–698.
Johnson, K. A., Simpson, Z. B., & Blom, T. (2009a). FitSpace explorer: An
algorithm to evaluate multidimensional parameter space in fitting
kinetic data. Analytical Biochemistry, 387, 30–41.
Johnson, K. A., Simpson, Z. B., & Blom, T. (2009b). Global kinetic explorer: A new computer program for dynamic simulation and fitting
of kinetic data. Analytical Biochemistry, 387, 20–29.
Jun, Y. W., & Kool, E. T. (2020). Small substrate or large? Debate over the
mechanism of glycation adduct repair by DJ-1. Cell Chemical Biology,
27, 1117–1123.

260

|

Junn, E., Jang, W. H., Zhao, X., Jeong, B. S., & Mouradian, M. M. (2009).
Mitochondrial localization of DJ-1 leads to enhanced neuroprotection. Journal of Neuroscience Research, 87, 123–129.
Kim, R. H., Peters, M., Jang, Y., Shi, W., Pintilie, M., Fletcher, G. C., DeLuca,
C., Liepa, J., Zhou, L., Snow, B., Binari, R. C., Manoukian, A. A., Bray,
M. R., Liu, F. F., Tsao, M. S., & Mak, T. W. (2005). DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell, 7, 263–273.
Kinumi, T., Kimata, J., Taira, T., Ariga, H., & Niki, E. (2004). Cysteine-106
of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-
mediated oxidation in vivo in human umbilical vein endothelial cells.
Biochemical and Biophysical Research Communications, 317, 722–728.
Kumar, R., Kumar, S., Hanpude, P., Singh, A. K., Johari, T., Majumder, S.,
& Maiti, T. K. (2019). Partially oxidized DJ-1 inhibits alpha-synuclein
nucleation and remodels mature alpha-synuclein fibrils in vitro.
Communications Biology, 2, 395.
Kwon, K., Choi, D., Hyun, J. K., Jung, H. S., Baek, K., & Park, C. (2013).
Novel glyoxalases from Arabidopsis thaliana. The FEBS Journal, 280,
3328–3339.
Lakshminarasimhan, M., Madzelan, P., Nan, R., Milkovic, N. M., & Wilson,
M. A. (2010). Evolution of new enzymatic function by structural
modulation of cysteine reactivity in Pseudomonas fluorescens
isocyanide hydratase. The Journal of Biological Chemistry, 285,
29651–29661.
Le Naour, F., Misek, D. E., Krause, M. C., Deneux, L., Giordano, T. J.,
Scholl, S., & Hanash, S. M. (2001). Proteomics-based identification
of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.
Clinical Cancer Research, 7, 3328–3335.
Lee, J. Y., Song, J., Kwon, K., Jang, S., Kim, C., Baek, K., Kim, J., & Park, C.
(2012). Human DJ-1 and its homologs are novel glyoxalases. Human
Molecular Genetics, 21, 3215–3225.
Lee, S. J., Kim, S. J., Kim, I. K., Ko, J., Jeong, C. S., Kim, G. H., Park, C., Kang,
S. O., Suh, P. G., Lee, H. S., & Cha, S. S. (2003). Crystal structures
of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain. The Journal of Biological Chemistry, 278,
44552–4 4559.
Lin, J., Prahlad, J., & Wilson, M. A. (2012). Conservation of oxidative
protein stabilization in an insect homologue of parkinsonism-
associated protein DJ-1. Biochemistry, 51, 3799–3807.
Lo, T. W., Westwood, M. E., McLellan, A. C., Selwood, T., & Thornalley,
P. J. (1994). Binding and modification of proteins by methylglyoxal
under physiological conditions. A kinetic and mechanistic study
with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-
acetyllysine, and bovine serum albumin. The Journal of Biological
Chemistry, 269, 32299–32305.
Lucas, J. I., & Marin, I. (2007). A new evolutionary paradigm for the
Parkinson disease gene DJ-1. Molecular Biology and Evolution, 24,
551–561.
MacKeigan, J. P., Clements, C. M., Lich, J. D., Pope, R. M., Hod, Y., &
Ting, J. P. (2003). Proteomic profiling drug-induced apoptosis
in non-small cell lung carcinoma: Identification of RS/DJ-1 and
RhoGDIalpha. Cancer Research, 63, 6928–6934.
Marmstal, E., Aronsson, A. C., & Mannervik, B. (1979). Comparison of
glyoxalase I purified from yeast (Saccharomyces cerevisiae) with
the enzyme from mammalian sources. The Biochemical Journal, 183,
23–3 0.
Martin-Nieto, J., Uribe, M. L., Esteve-Rudd, J., Herrero, M. T., & Campello,
L. (2019). A role for DJ-1 against oxidative stress in the mammalian
retina. Neuroscience Letters, 708, 134361.
Matsuda, N., Kimura, M., Queliconi, B. B., Kojima, W., Mishima, M.,
Takagi, K., Koyano, F., Yamano, K., Mizushima, T., Ito, Y., & Tanaka,
K. (2017). Parkinson's disease-related DJ-1 functions in thiol quality
control against aldehyde attack in vitro. Scientific Reports, 7, 12816.
Mazza, M. C., Beilina, A., Roosen, D. A., Hauser, D., & Cookson, M. R.
(2021). Generation of iPSC line from a Parkinson patient with
PARK7 mutation and CRISPR-edited Gibco human episomal iPSC
line to mimic PARK7 mutation. Stem Cell Research, 55, 102506.

MAZZA et al.

Mita, Y., Kataoka, Y., Saito, Y., Kashi, T., Hayashi, K., Iwasaki, A., Imanishi,
T., Miyasaka, T., & Noguchi, N. (2018). Distribution of oxidized DJ-1
in Parkinson's disease-related sites in the brain and in the peripheral
tissues: Effects of aging and a neurotoxin. Scientific Reports, 8, 12056.
Mitsugi, H., Niki, T., Takahashi-Niki, K., Tanimura, K., Yoshizawa-
Kumagaye, K., Tsunemi, M., Iguchi-Ariga, S. M., & Ariga, H. (2013).
Identification of the recognition sequence and target proteins for
DJ-1 protease. FEBS Letters, 587, 2493–2499.
Moraru, A., Wiederstein, J., Pfaff, D., Fleming, T., Miller, A. K., Nawroth,
P., & Teleman, A. A. (2018). Elevated levels of the reactive metabolite methylglyoxal recapitulate progression of type 2 diabetes. Cell
Metabolism, 27(926–934), e928.
Mulikova, T., Bekkhozhin, Z., Abdirassil, A., & Utepbergenov, D. (2021). A
continuous spectrophotometric assay for glutathione-independent
glyoxalases. Analytical Biochemistry, 630, 114317.
Nagakubo, D., Taira, T., Kitaura, H., Ikeda, M., Tamai, K., Iguchi-Ariga, S.
M., & Ariga, H. (1997). DJ-1, a novel oncogene which transforms
mouse NIH3T3 cells in cooperation with ras. Biochemical and
Biophysical Research Communications, 231, 509–513.
Natkanska, U., Skoneczna, A., Sienko, M., & Skoneczny, M. (2017). The
budding yeast orthologue of Parkinson's disease-associated DJ-1
is a multi-stress response protein protecting cells against toxic
glycolytic products. Biochimica et Biophysica Acta -Molecular Cell
Research, 1864, 39–50.
Olzmann, J. A., Brown, K., Wilkinson, K. D., Rees, H. D., Huai, Q., Ke, H.,
Levey, A. I., Li, L., & Chin, L. S. (2004). Familial Parkinson's disease-
associated L166P mutation disrupts DJ-1 protein folding and function. The Journal of Biological Chemistry, 279, 8506–8515.
Oswald, M. C., Brooks, P. S., Zwart, M. F., Mukherjee, A., West, R. J.,
Giachello, C. N., Morarach, K., Baines, R. A., Sweeney, S. T., &
Landgraf, M. (2018). Reactive oxygen species regulate activity-
dependent neuronal plasticity in drosophila. eLife, 7, e39393.
Pfaff, D. H., Fleming, T., Nawroth, P., & Teleman, A. A. (2017). Evidence
against a role for the parkinsonism-associated protein DJ-1 in
methylglyoxal detoxification. The Journal of Biological Chemistry,
292, 685–690.
Richarme, G., Abdallah, J., Mathas, N., Gautier, V., & Dairou, J. (2018).
Further characterization of the Maillard deglycase DJ-1 and its
prokaryotic homologs, deglycase 1/Hsp31, deglycase 2/YhbO,
and deglycase 3/YajL. Biochemical and Biophysical Research
Communications, 503, 703–709.
Richarme, G., & Dairou, J. (2017). Parkinsonism-associated protein DJ-1
is a bona fide deglycase. Biochemical and Biophysical Research
Communications, 483, 387–391.
Richarme, G., Liu, C., Mihoub, M., Abdallah, J., Leger, T., Joly, N., Liebart,
J. C., Jurkunas, U. V., Nadal, M., Bouloc, P., Dairou, J., & Lamouri,
A. (2017). Guanine glycation repair by DJ-1/Park7 and its bacterial
homologs. Science, 357, 208–211.
Richarme, G., Mihoub, M., Dairou, J., Bui, L. C., Leger, T., & Lamouri,
A. (2015). Parkinsonism-associated protein DJ-1/Park7 is a major
protein deglycase that repairs methylglyoxal- and glyoxal-glycated
cysteine, arginine, and lysine residues. The Journal of Biological
Chemistry, 290, 1885–1897.
Shadrach, K. G., Rayborn, M. E., Hollyfield, J. G., & Bonilha, V. L. (2013).
DJ-1-dependent regulation of oxidative stress in the retinal pigment epithelium (RPE). PLoS One, 8, e67983.
Sharma, N., Rao, S. P., & Kalivendi, S. V. (2019). The deglycase activity of
DJ-1 mitigates alpha-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1
in Parkinson's disease. Free Radical Biology & Medicine, 135, 28–37.
Shendelman, S., Jonason, A., Martinat, C., Leete, T., & Abeliovich, A.
(2004). DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biology, 2, e362.
Shuck, S. C., Wuenschell, G. E., & Termini, J. S. (2018). Product studies
and mechanistic analysis of the reaction of methylglyoxal with deoxyguanosine. Chemical Research in Toxicology, 31, 105–115.

|

MAZZA et al.

Subedi, K. P., Choi, D., Kim, I., Min, B., & Park, C. (2011). Hsp31 of
Escherichia coli K-12 is glyoxalase III. Molecular Microbiology, 81,
926–936.
Taira, T., Saito, Y., Niki, T., Iguchi-Ariga, S. M., Takahashi, K., & Ariga, H.
(2004). DJ-1 has a role in antioxidative stress to prevent cell death.
EMBO Reports, 5, 213–218.
Thornalley, P. J. (1990). The glyoxalase system: New developments towards functional characterization of a metabolic pathway fundamental to biological life. The Biochemical Journal, 269, 1–11.
van der Brug, M. P., Blackinton, J., Chandran, J., Hao, L. Y., Lal, A., Mazan-
Mamczarz, K., Martindale, J., Xie, C., Ahmad, R., Thomas, K. J.,
Beilina, A., Gibbs, J. R., Ding, J., Myers, A. J., Zhan, M., Cai, H., Bonini,
N. M., Gorospe, M., & Cookson, M. R. (2008). RNA binding activity
of the recessive parkinsonism protein DJ-1 supports involvement in
multiple cellular pathways. Proceedings of the National Academy of
Sciences of the United States of America, 105, 10244–10249.
Vazquez-Mayorga, E., Diaz-Sanchez, A. G., Dagda, R. K., Dominguez-
Solis, C. A., Dagda, R. Y., Coronado-Ramirez, C. K., & Martinez-
Martinez, A. (2016). Novel redox-dependent esterase activity (EC
3.1.1.2) for DJ-1: Implications for Parkinson's disease. International
Journal of Molecular Sciences, 17, 1346.
Waak, J., Weber, S. S., Gorner, K., Schall, C., Ichijo, H., Stehle, T., & Kahle,
P. J. (2009). Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating
kinase 1. The Journal of Biological Chemistry, 284, 14245–14257.
Wei, Y., Ringe, D., Wilson, M. A., & Ondrechen, M. J. (2007). Identification
of functional subclasses in the DJ-1 superfamily proteins. PLoS
Computational Biology, 3, e10.
Wilson, M. A., Ringe, D., & Petsko, G. A. (2005). The atomic resolution
crystal structure of the YajL (ThiJ) protein from Escherichia coli: A
close prokaryotic homologue of the parkinsonism-associated protein DJ-1. Journal of Molecular Biology, 353, 678–691.
Witt, A. C., Lakshminarasimhan, M., Remington, B. C., Hasim, S.,
Pozharski, E., & Wilson, M. A. (2008). Cysteine pKa depression
by a protonated glutamic acid in human DJ-1. Biochemistry, 47,
7430–7440.

261

Xu, S., Yang, X., Qian, Y., & Xiao, Q. (2018). Parkinson's disease-related
DJ-1 modulates the expression of uncoupling protein 4 against oxidative stress. Journal of Neurochemistry, 145, 312–322.
Zepeta-Flores, N., Valverde, M., Lopez-S aavedra, A., & Rojas, E. (2018).
Glutathione depletion triggers Actin cytoskeleton changes
via Actin-binding proteins. Genetics and Molecular Biology, 41,
475–4 87.
Zhao, Q., Su, Y., Wang, Z., Chen, C., Wu, T., & Huang, Y. (2014).
Identification of glutathione (GSH)-independent glyoxalase III from
Schizosaccharomyces pombe. BMC Evolutionary Biology, 14, 86.
Zheng, Q., Omans, N. D., Leicher, R., Osunsade, A., Agustinus, A. S.,
Finkin-Groner, E., D'Ambrosio, H., Liu, B., Chandarlapaty, S., Liu,
S., & David, Y. (2019). Reversible histone glycation is associated
with disease-related changes in chromatin architecture. Nature
Communications, 10, 1289.
Zhou, W., Zhu, M., Wilson, M. A., Petsko, G. A., & Fink, A. L. (2006).
The oxidation state of DJ-1 regulates its chaperone activity toward
alpha-synuclein. Journal of Molecular Biology, 356, 1036–1048.

S U P P O R T I N G I N FO R M AT I O N
Additional supporting information can be found online in the
Supporting Information section at the end of this article.

How to cite this article: Mazza, M. C., Shuck, S. C., Lin, J.,
Moxley, M. A., Termini, J., Cookson, M. R., & Wilson, M. A.
(2022). DJ-1 is not a deglycase and makes a modest
contribution to cellular defense against methylglyoxal damage
in neurons. Journal of Neurochemistry, 162, 245–261. https://
doi.org/10.1111/jnc.15656

